Related Experiment Videos
Cerebral metastases from malignant melanoma
1Department of Clinical Neurological Sciences, Victoria Hospital, London, Ontario, Canada.
Summary
Malignant melanoma can spread to the brain, causing neurological issues. Surgical removal of single brain metastases from melanoma offers improved survival rates compared to radiotherapy for multiple metastases.
Area of Science:
- Oncology
- Neurology
- Surgical Oncology
Background:
- Malignant melanoma is a significant public health concern.
- Brain metastases from melanoma can lead to severe neurological deficits.
- Understanding the prognostic factors and treatment outcomes for melanoma brain metastases is crucial.
Purpose of the Study:
- To analyze the incidence and characteristics of brain metastases in patients with primary malignant melanoma.
- To evaluate the survival outcomes based on the number of brain lesions and treatment modalities.
- To determine the efficacy of surgical intervention for single brain metastases.
Main Methods:
- Retrospective analysis of 552 patients with primary malignant melanoma.
- Data collected from 1960 to 1985 at the London Regional Cancer Centre.
- Focus on patients who developed neurological signs and symptoms of brain metastases.
Main Results:
- Brain metastases occurred in 8.4% of patients.
- Single metastasis (39% of cases) had a 58% six-month survival with surgery, and 25% survived over two years.
- Multiple metastases treated with radiotherapy showed a 12% survival beyond six months.
Conclusions:
- Surgical excision of single brain metastases from malignant melanoma is associated with improved survival.
- Patients with multiple brain metastases have a poorer prognosis even with radiotherapy.
- Early detection and surgical management of solitary melanoma brain lesions should be considered.